Long-Term Safety Study of KW-6002 (Istradefylline) in Parkinson's Disease Patients
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
Patients with Parkinson's disease who completed the prior double-blind study 6002-009 are
eligible to enter into this long-term study. The purpose of this study is to evaluate the
safety and efficacy of KW-6002 administered long-term in patients with advanced Parkinson's
disease treated with levodopa.
Phase:
Phase 3
Details
Lead Sponsor:
Kyowa Hakko Kirin Company, Limited Kyowa Kirin Co., Ltd.